Table 4.

Crosses used in in vivo infections.

Cross	No. of infected mice	No. of times parent 1 was isolated	No. of times parent 2 was isolated	No. of times double drug-resistant parasites were isolated	% Recovery
L. amaz LPG2/LPG2::ΔHYG × L. amaz +/SSU::NEO-GFP	13	13	13	0	0%
L. mex. LPG2/LPG2::ΔHYG × L. amaz +/SSU::NEO-GFP	6	6	6	0	0%

Data includes the number of infected mice with each cross and parasite strains that were isolated from each infection. Percentage indicates the total number of times that double drug-resistant parasites were isolated.